ProPhase Labs to effect 1-for-10 reverse stock split to maintain Nasdaq listing

ProPhase Labs, Inc.

Stockholders approved reverse stock split on Nov 24, 2025; board approved Nov 30, 2025.
Certificate of Amendment filed Dec 2, 2025; split effective Dec 22, 2025 at 8:00 AM ET.
After split, approximately 5,768,951 shares of common stock will be outstanding.
No fractional shares; any fractional shares rounded up to whole share.
Reverse split intended to increase per-share price to meet Nasdaq continued listing requirements.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

ProPhase Labs, Inc.: Amended Certificate of Incorporation to effect a 1-for-10 reverse stock split of common stock (effective 2025-12-02).

Change: charter amendment
Effective: 2025-12-02

Exact text from the filing

On December 2, 2025, ProPhase Labs, Inc., a Delaware corporation (the “Company”), filed a Certificate of Amendment (the “Certificate of Amendment”) to its Certificate of Incorporation with the Secretary of State of the State of Delaware to effect a 1-for-10 reverse stock split of the Company’s issued and outstanding shares of common stock, par value $0.0005 per share (the “Common Stock”) (the “Reverse Stock Split”). The Certificate of Amendment became effective on December 2, 2025.

View on SEC.gov

84 governance changes filed in the last 30 days. Browse all governance changes →

ProPhase Labs, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-027399

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.